Sign In
Buy SNN
$31.56
-0.770 (-2.38%)
At Close: Jul 31, 2026
Smith & Nephew plunges as weaker US knees
07:01am, Thursday, 06'th Nov 2025
Smith & Nephew PLC (LSE:SN) shares were the worst faller on the FTSE 100 on Thursday morning, down 12% after reporting lower revenues than expected Third-quarter revenue growth came in at 5.0%, below
Envestnet Asset Management Inc. Lowers Stock Position in Smith & Nephew SNATS, Inc. $SNN
03:52am, Thursday, 06'th Nov 2025
Envestnet Asset Management Inc. lowered its position in Smith and Nephew SNATS, Inc. (NYSE: SNN) by 12.1% in the undefined quarter, according to the company in its most recent Form 13F filing with the
Smith & Nephew: Expensive Valuations And Muted Growth May Dampen Upcoming Q3 Earnings Release
09:58am, Wednesday, 05'th Nov 2025
Smith & Nephew plc maintains a 'Hold' rating due to valuation concerns and limited near-term upside despite recent operational improvements. Sequential growth across all business units and a 100 basis
Ethic Inc. Reduces Holdings in Smith & Nephew SNATS, Inc. $SNN
03:37am, Wednesday, 29'th Oct 2025
Ethic Inc. trimmed its stake in Smith and Nephew SNATS, Inc. (NYSE: SNN) by 17.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces findings from a newly published, first-of-its-kind comparative study of single-use negative pressure wound thera
UFC® and Smith+Nephew announce multi-year extension of partnership
11:30am, Wednesday, 22'nd Oct 2025
Smith+Nephew to continue as UFC's Preferred Sports Medicine Technology Partner Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, and UFC the world's premier mixed martial arts or
Smith+Nephew announces new category I CPT® code for its CARTIHEAL™ AGILI-C™ Cartilage Repair Implant
04:30pm, Thursday, 09'th Oct 2025
SmithNephew (LSE: SN, NYSE: SNN), the global medical technology company, today announces that the American Medical Association (AMA) CPT Editorial Panel has established a Category I Current Procedural
SNN or SYK: Which Is the Better Value Stock Right Now?
12:41pm, Wednesday, 08'th Oct 2025
Investors interested in stocks from the Medical - Products sector have probably already heard of Smith & Nephew (SNN) and Stryker (SYK). But which of these two stocks presents investors with the bette
Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology business, is pleased to announce exciting new data from Professor Amit Gefen and his research group published in the International Wound
Smith+Nephew launches CORIOGRAPH™ Pre-Op Planning and Modeling Services for total shoulder arthroplasty
01:00pm, Wednesday, 01'st Oct 2025
Completes the CORIOGRAPH Services portfolio which also includes solutions for knee and hip arthroplasty Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the laun
Should Value Investors Buy Smith & Nephew SNATS (SNN) Stock?
10:41am, Thursday, 25'th Sep 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
SNN vs. SYK: Which Stock Is the Better Value Option?
12:40pm, Monday, 22'nd Sep 2025
Investors interested in stocks from the Medical - Products sector have probably already heard of Smith & Nephew (SNN) and Stryker (SYK). But which of these two companies is the best option for those l
Smith+Nephew unveils major clinical evidence and patient access updates for its REGENETEN™ Bioinductive Implant
08:00am, Thursday, 11'th Sep 2025
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces new evidence and market updates that highlight the clinical performance of its REGENETEN Bioinductive Implant an
Smith+Nephew extends Advanced Wound Bioactives portfolio with US launch of CENTRIO Platelet-Rich-Plasma System
10:16am, Wednesday, 03'rd Sep 2025
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of the CENTRIO Platelet-Rich-Plasma (PRP) System, a biodynamic hematogel derived from a patient's own
Are Investors Undervaluing Smith & Nephew SNATS (SNN) Right Now?
05:31pm, Tuesday, 02'nd Sep 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
